Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altamira Therapeutics Ltd...

    NASDAQ: CYTO · Real-Time Price · USD
    0.30
    0.00 (0.00%)
    At close: Jan 16, 2025, 9:00 PM

    Altamira Therapeutics Revenue

    Altamira Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending June 30, 2023, Altamira Therapeutics generated $52.73K in revenue.
    Revenue (ttm)
    $0
    Revenue Growth
    -100%
    Price / Sales Ratio
    0
    Revenue / Employee
    $0
    Employees
    10
    Market Cap
    1.13M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist